Communitarian policies in relation to doping markets. The evolution of the distribution of doping products in cycling;Des pratiques communautaires au marché du dopage: Évolution de la distribution des produits dopants dans le cyclisme

Deviance et Societe

Volumn 38, Issue 1, 2014, Pages 3-28

  Fincoeur, Bertrand ^a   Paoli, Letizia ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84904279509     PISSN: 03787931     EISSN: None     Source Type: Journal    
DOI: 10.3917/ds.381.0003     Document Type: Article

References (87)

1. BASSONS C., 2000, Positif, Paris, Stock.
2. BECKER H.S., 1985, Outsiders, Paris, Métailié.
3. BERGER P., LUCKMANN T., 1986, La construction sociale de la réalité, Paris, Méridiens Klincksieck.
4. BILARD J., NINOT G., HAUW D., 2011, Motives for Illicit Use of Doping Substances Among Athletes Calling a National Anti-Doping Phone-Help Service: An Exploratory Study, Substance Use & Misuse, 46, 4, 359-367.
5. BINSINGER C., FRISER A., 2002, Du dopage en particulier aux conduites dopantes en général: le point sur les connaissances, Psychotropes, 8, 3-4, 9-22.
6. BOJSEN-MØLLER J., CHRISTIANSEN A.V., 2010, Use of performance- and image-enhancing substances among recreational athletes: a quantitative analysis of inquiries submitted to the Danish anti-doping authorities, Scandinavian Journal of Medicine & Science in Sports, 20, 861-867.
7. e Colloque National de Lutte et de Prévention du Dopage, Paris, CNOSF, 75-81.
8. BRISSONNEAU C., 2007, Le dopage dans le cyclisme professionnel au milieu des années 1990: une reconstruction des valeurs sportives, Déviance et Société, 31, 2, 129-148.
9. BRISSONNEAU C., AUBEL O., OHL F., 2008, L'épreuve du dopage. Sociologie du cyclisme professionnel, Paris, PUF.
10. BRISSONNEAU C., DEFRANCE J., FINCOEUR B., LENTILLON-KAESTNER V., OHL F., 2009, Carrière sportive et socialisation secondaire en cyclisme sur route: les cas de la Belgique, la France et la Suisse, Lausanne, World Anti-Doping Agency.
11. BRISSONNEAU C., LE NOÉ O., 2006, Construction d'un problème public autour du dopage et reconnaissance d'une spécialité médicale, Sociologie du travail, 48, 487-508. (Pubitemid 44873802)
12. BUISINE S., 2006, Le jeu des cyclistes face à leurs contrats professionnels, Communication affichée au Congrès de l'Association Française de Sociologie, RT31.
13. CAZUC C., 2007, Le tennis professionnel masculin face au dopage: perspectives critiques. Papier présenté au congrès Sports, violences et racisme, Université de Rennes, Conseil de l'Europe, avril.
14. CHIOTTI J., 2001, De mon plein gré, Paris, Calmann-Lévy.
15. CHRISTIANSEN A.V., 2005, The Legacy of Festina: Patterns of Drug Use in European Cycling Since 1998, Sports in History, 25, 3, 497-514.
16. CLOWARD R.A., OHLIN L.E., 1960, Delinquency and Opportunity: A Theory of Delinquent Gangs, New York, Free Press.
17. COAKLEY J., PIPE E., 2009, Sport in Society: Issues and Controversies, Boston, McGraw Hill.
18. DE LESELEUC E., MARCELLINI A., 2005, Légitimité vs illégitimité du dopage chez les sportifs de haut niveau. Comment se définissent les limites du non-acceptable? Staps, 70, 33-47.
19. DEMESLAY J., TRABAL P., 2007, De quelques contraintes du processus d'harmonisation des politiques antidopage, Terrains & Travaux, 1, 138-162.
20. DE MONDENARD J.P., 2011, Tour de France: 33 vainqueurs face au dopage entre 1947 et 2010, Paris, Hugo & Cie.
21. D'HONT J., 2007, Memoires van een wielerverzorger, Leuven, Van Halewyck.
22. DIMEO P, McNAMEE M, MØLLER V., 2009, Elite Sports, Doping and Public Health, Odense, University Press of Southern Denmark.
23. DONATI A., 2007, World Traffic in Doping Substances, Lausanne, World Anti-Doping Agency.
24. DUMESTRE-TOULET V., 2000, Se doper via l'Internet? Un jeu⋯ de souris! Annales Toxicologie Analytique, 12, 1, 19-25.
25. DUNN M., THOMAS J., SWIFT W., BURNS L., MATTICK R., 2010, Drug testing in sport: The attitudes and experiences of elite athletes, International Journal of Drug Policy, 21,4,330-332.
26. DUNNING E., 1986, The Dynamics of Modern Sport: Notes on the Achievement-Striving and the Social Significance of Sport, in ELIAS N., DUNNING E. (Eds), Quest for Excitement, Oxford, Blackwell, 205-223.
27. DURET P., TRABAL P., 2001, Le sport et ses affaires. Une sociologie de la justice de l'épreuve sportive, Paris, Métailié.
28. EHRENBERG A., 1991, Le culte de la performance, Paris, Calmann-Lévy.
29. ELKIN S.L., BRADY S., WILLIAMS I.P., 1997, Bodybuilders find it easy to obtain insulin to help them in training, British Medical Journal, 314, 1280. (Pubitemid 27173924)
30. EMCDDA, 2013, EU Drug Markets Report. A Strategic Analysis, Lisbonne, rapport en ligne [http://www.emcdda.europa.eu/publications/joint-publications/ drug-markets].
31. ENGELBERG T., MOSTON S., SKINNER J., 2012, Public perception of sport anti-doping policy in Australia, Drugs: Education, Prevention & Policy, 19, 1, 84-87.
32. ESCRIVA J.P., 2001, Sport intensif et dopages entre normes et déviances, Sociétés contemporaines, 44, 129-147.
33. FIGNON L., 2009, Nous étions jeunes et insouciants, Paris, Grasset.
34. FINCOEUR B., 2009a, Jusqu'où va-t-on au nom de l'éthique? La lutte antidopage dans le cyclisme sur route, Revue de la Faculté de droit de l'Université de Liège, 4, 613-623.
35. FINCOEUR B., 2009b, Lutte antidopage et cyclisme à deux vitesses: évolution du rapport au dopage chez les cyclistes belges depuis l'affaire Festina, Revue internationale de criminologie et de police technique et scientifique, 3, 207-220.
36. FINCOEUR B., 2010, La question du dopage à l'aune des étapes de la carrière cycliste, Cahiers de la Sé curité, 11, 72-81.
37. GAUMONT P., 2005, Prisonnier du dopage, Paris, Grasset.
38. HAMILTON T., COYLE D., 2012, The Secret Race: Inside the Hidden World of the Tour de France: Doping, Cover-ups, and Winning at All Costs, New York, Bantam.
39. HANSTAD D.V., 2009, Anti-Doping in Sport: A Study of Policy Development since 1998, Oslo, Norwegian School of Sport Sciences.
40. HANSTAD D.V., LOLAND S., 2009, Elite Level Athletes' Duty to Provide Information on Their Whereabouts: Justifiable Anti-doping Work or an Indefensible Surveillance Regime? European Journal of Sport Sciences, 9, 1, 3-10.
41. HANSTAD D.V., SMITH A., WADDINGTON I., 2008, The Establishment of the World Anti-Doping Agency: A Study of the Management of Organizational Change and Unplanned Outcomes, International Review for the Sociology of Sport, 43, 3, 227-249.
42. st Century, Leuven, Leuven University Press, 181-205.
43. HOBERMAN J.M., 2001, How Drug Testing Fails. The Politics of Doping Control, in WILSON W., DERSE E. (Eds), Doping in Elite Sport, Champaign, Human Kinetics, 241-274.
44. HOBERMAN J.M., 2002, A Pharmacy on Wheels: Doping and Community Cohesion among Professional Cyclists Following the Tour de France Scandal of 1998, in MØLLER V., NAURIGHT J. (Eds), The Essence of Sport, Odense, University Press of Southern Denmark, 107-127.
45. HOULIHAN B., 2002, Dying to Win: Doping in Sport and the Development of Anti-doping Policy, Strasbourg, Council of Europe.
46. KAMBER M., 2011, Development of the role of National Anti-Doping Organizations in the fight against doping: From past to future, Forensic Science International, 23, 7-9.
47. KANAYAMA G., GRUBER A.J., POPE H.G., BOROWIECKI J.J., HUDSON J.L., 2001, Over-the-Counter Drug Use in Gymnasiums: An Underrecognized Substance Abuse Problem? Psychotherapy and Psychosomatics, 70, 137-140. (Pubitemid 32429714)
48. KANAYAMA G., HUDSON J., POPE G., 2010, Illicit Anabolic-Androgenic Steroid Use, Hormones and Behavior, 58, 1, 11-21.
49. KAYSER B., MAURON A., MIAH A., 2007, Current Anti-Doping Policy: A Critical Appraisal, BMC Medical Ethics, 8, 2.
50. KIMMAGE P., 1998, Rough Rude. Behind the Wheel with a Pro Cyclist, London, Yellow Jersey Press.
51. KINDLUNDH A.M., ISACSON D.G., BERGLUND L., NYBERG F., 1998, Doping among high school students in Uppsala, Sweden: a presentation of the attitudes, distribution, side effects, and extent of use, Scandinavian journal of Social Medicine, 26, 71-74.
52. KOERT A., van KLEIJ R., 2002, The Doping Trade: An Exploratory Study into the Trade of Performance Enhancing Drugs in the Netherlands, in PETERS C, SCHULZ T., MICHNA H. (Eds), Biomedical Side Effects of Doping. Project for the European Union, Cologne, Sport und Buch Strauss.
53. KORNBECK J., 2010, The fight against Doping: Does the EU have a potential to harmonize after the entry into force of the Lisbon Treaty? Monatsschrift für Kriminologie und Strafrechtsreform, 93, 3, 198-213.
54. KRASKA P., BUSSARD C, BRENT J., 2010, Trafficking in Bodily Perfection: Examining the Late-Modern Steroid Marketplace and its Criminalization, Justice Quarterly, 27, 2, 159-185.
55. LÊ-GERMAIN E., LECA R., 2005, Les conduites dopantes fondatrices d'une sous-culture cycliste (1965-1999), Staps, 70, 109-125.
56. LENTILLON-KAESTNER V., 2008, Conduites dopantes chez les jeunes cyclistes du milieu amateur au milieu professionnel, Psychotropes, 14, 1, 41-57.
57. LENTILLON-KAESTNER V., BRISSONNEAU C., 2009, Appropriation progressive de la culture du dopage dans le cyclisme, Déviance et Société , 33, 4, 519-541.
58. LORANG M., CALLAHAN B., CUMMINS K., ACHAR S., BROWN S., 2011, Anabolic Androgenic Steroid Use in Teens: Prevalence, Demographics and Perception of Effects, Journal of Child & Adolescent Substance Abuse, 20, 4, 358-369.
59. MENTHÉOUR E., 1999, Secret défonce. Ma vérité sur le dopage, Paris, Lattès.
60. MERTON R.K., 1968, Social Theory and Social Structure, New York, Free Press.
61. NILSSON S., 1995, Androgenic anabolic steroid use among male adolescents in Falkenberg, European Journal of Clinical Pharmacology, 1, 9-11.
62. OLDERSMA F., SNIPPE J., BIELEMAN B., 2002, Doping en handel: Onderzoek naar aard en omvang van dopinghandel en ontwikkeling van indicatoren, Groningen/Rotterdam, Bureau Intraval.
63. PAOLI L., DONATI A., 2012, The Trade in Doping Products and the Challenges of Supply Reduction: An Examination of Italy's Experience, Lausanne, World Anti-Doping Agency.
64. PAOLI L., GREENFIELD V.A., REUTER P., 2009, The World Heroin Market: Can Supply Be Cut? New York, Oxford University Press.
65. PASCHE D.R., MARCLAY B., 2011, Les trafics des produits dopants et les moyens mis en oeuvre pour les freiner, in OSWALD D., JACCOUD C. (Eds), Le dopage dans le sport. État des lieux et nouvelles perspectives, Neuchâtel, Éditions CIES.
66. PERERA E., GLEYSE J., 2005, Le dopage dans quatre grands périodiques sportifs français de 1903 aux années soixante. Le secret, le pur et l'impur, Staps, 70, 89-107.
67. PETROCZI A., MAZANOV J., NEPUS T., BACKHOUSE S.H., NAUGHTON D.P., 2008, Comfort in Big Numbers: Does Over-Estimation of Doping Prevalence in Others Indicate Self-Involvement? Journal of Occupational Medicine and Toxicology, 3, 19.
68. PITSCH W., EMRICH E., 2011, The frequency of doping in elite sport: Results of a replication study, International Review for the Sociology of Sport, 1-22.
69. PITSCH W., EMRICH E., KLEIN M., 2007, Doping in elite sports in Germany: results of a survey, European Journal for Sport and Society, 4, 89-102.
70. RABIN O., 2011, Involvement of the health industry in the fight against doping, Forensic Science International, 23, 10-14.
71. ROUSSEL B., 2001, Tour de vices, Paris, Hachette.
72. SALLÉ L., LESTRELIN L., BASSON J.-C., 2006, Le Tour de France 1998 et la régulation du dopage sportif: reconfiguration des rapports de force, Staps, 73, 9-23.
73. SCOTT D.M., WAGNER J.C., BARLOW T.W., 1996, Anabolic steroid use among adolescents in Nebraska schools, American Journal of Health System Pharmacy, 53, 2068-2072. (Pubitemid 26291957)
74. SIMON P., 2011, How Many Athletes Dope? Doping and Prevalence, Présentation au Symposium International, Sportmedizin und Doping in Europa, Freiburg, 12-14 septembre.
75. SMITH A., STEWART B., 2008, Drug policy in sport: hidden assumptions and inherent contradictions, Drug & Alcohol Review, 27, 2, 123-129.
76. SOULE B., LESTRELIN L., 2011, The Puerto Affair: Revealing the Difficulties of the Fight Against Doping, Journal of Sport and Social Issues, 35, 186-208.
77. SPITZER G., 2005, Approche historique du dopage en République démocratique allemande: description et analyse d'un système de contraintes étatiques, Staps, 70, 49-58.
78. STRIEGEL H., ULRICH R., SIMON P., 2010, Randomized Response Estimates for Doping and Illicit Drug Use in Elite Athletes, Drug and Alcohol Dependence, 106, 230-232.
79. STRIEGEL H., SIMON P., NIESS A.M., ULRICH R., 2007, Nutritional Supplement and Illicit Drug Use in Elite Athletes, Medicine & Science in Sports & Exercise, 39,5,457-465.
80. SYKES G., MATZA D., 1957, Techniques of Neutralisation: A Theory of Delinquency, American Sociological Review, 22, 6, 664-670.
81. TAMBURRINI C., 2006, Are Doping Sanctions Justified ? A Moral Relativistic View, Sport in Society, 9, 2, 199-211. (Pubitemid 43348679)
82. TANNER S.M., MILLER D.W., ALONGI C., 1995, Anabolic steroid use by adolescents: prevalence, motives and knowledge of risks, Clinical Journal of Sports Medicine, 2, 108-115.
83. THEVIS M., GEYER H., THOMAS A., SCHÄNZER W., 2011, Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet, Drug Testing & Analysis, 3, 5, 331-336.
84. VOET W., 1999, Massacre à la chaîne, révé lations sur 30 ans de tricherie, Paris, Calmann-Lévy.
85. VOLKWEIN K., 1995, Ethics and Top-Level Sport - A Paradox ? International Review for Sociology of Sport, 30, 311-320.
86. WADDINGTON I., SMITH A., 2009, An Introduction to Drugs in Sport: Addicted to Winning? London, Routledge.
87. YESALIS C.E., KOPSTEIN A.N., BAHRKE M.S., 2001, Difficulties in Estimating the Prevalence of Drug Use among Athletes, in WILSON W, DERSE E. (Eds), Doping in Elite Sport: the Politics of Drugs in the Olympic Movement, Champaign, Human Kinetics, 43-62.